Delivery Order SPE2DB20D3103-SPE2DB23FP6Z8

Award Date 9/12/23
Potential Completion Date 9/13/23
Potential Value $14K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The award, valued at $99,191.56, is for the supply of medical products, including the drug TRIUMEQ 600-50-300 MG Tablet. The contract has a completion date of March 14, 2022, and there was no set-aside designation. Amerisourcebergen, as a major...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $17,592.43, is for the delivery of TRIUMEQ 600-50-300 MG TABLET UU 30S, a pharmaceutical product. The award is a Firm Fixed Price Delivery Order with a completion date of May 6, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $80,352.58, is for the delivery of TRIUMEQ 600-50-300 MG TABLET medical products. The award is a delivery order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $8,903.41 firm-fixed-price delivery order is for TRIUMEQ 600-50-300 MG TABLET UU 30S, a pharmaceutical product. This contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
This federal contract award, valued at $20,608.85, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Triumeq 600-50-300 mg tablets, a pharmaceutical product. The contract is a delivery order with a firm fixed price. The award has no set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp is the prime contractor, and it holds a significant Indefinite Delivery...
This federal contract award, valued at $89,233.74, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract involves the delivery of TRIUMEQ 600-50-300 MG TABLET UU 30S, a pharmaceutical product, to support military healthcare programs. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $34,901.76, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order that provides the DLA with TRIUMEQ 600-50-300 MG TABLET, a pharmaceutical product, under a Firm Fixed Price pricing structure. The contract has an ultimate completion date of November 7, 2024. This contract award is associated with a larger Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of TRIUMEQ 600-50-300 MG TABLET. The contract, valued at $13,394.17, is a firm fixed-price delivery order with a completion date of February 27, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is to provide TRICARE pharmaceutical and medical supplies for the Defense Logistics Agency (DLA) Troop Support Medical. The $1,340.05 delivery order is a firm-fixed-price contract with no set-aside designation. It is a part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $93,942.54 firm fixed-price delivery order is for the supply of Triumeq 600-50-300 mg tablets. The award is not associated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC serves as...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB23FP6Z8
    Delivery Order

This federal contract award involves the delivery of pharmaceutical products and medical supplies from Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, with a ceiling value of $14,301.00, covers the delivery of TRIUMEQ 600-50-300 MG TABLET medication. This is a delivery order awarded under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA, valued at up to $999,999,999.00 and running through December 2025. The contract does not have a set-aside designation, indicating open competition. This award demonstrates Amerisourcebergen's role as a critical supplier of essential pharmaceutical and medical commodities to support military healthcare programs and facilities worldwide.

Generated 2/27/25, 12:49 PM